nodes	percent_of_prediction	percent_of_DWPC	metapath
Trilostane—Oxandrolone—Spironolactone—dilated cardiomyopathy	0.4	0.413	CrCrCtD
Trilostane—Progesterone—Spironolactone—dilated cardiomyopathy	0.2	0.206	CrCrCtD
Trilostane—Methyltestosterone—Spironolactone—dilated cardiomyopathy	0.195	0.201	CrCrCtD
Trilostane—Testosterone—Spironolactone—dilated cardiomyopathy	0.173	0.179	CrCrCtD
Trilostane—ESR1—LKB1 signaling events—SIK1—dilated cardiomyopathy	0.00213	0.0677	CbGpPWpGaD
Trilostane—ESR2—Nuclear Receptor transcription pathway—NR3C2—dilated cardiomyopathy	0.00194	0.0615	CbGpPWpGaD
Trilostane—HSD3B1—Corticotropin-releasing hormone—GJA1—dilated cardiomyopathy	0.00141	0.0448	CbGpPWpGaD
Trilostane—ESR1—FOXM1 transcription factor network—LAMA4—dilated cardiomyopathy	0.00134	0.0426	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00118	0.0375	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.00114	0.0363	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00111	0.0352	CbGpPWpGaD
Trilostane—HSD3B2—Corticotropin-releasing hormone—GJA1—dilated cardiomyopathy	0.00107	0.034	CbGpPWpGaD
Trilostane—ESR1—Nuclear Receptor transcription pathway—NR3C2—dilated cardiomyopathy	0.000978	0.031	CbGpPWpGaD
Trilostane—Progesterone—NR3C2—dilated cardiomyopathy	0.000947	1	CrCbGaD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—ZBTB17—dilated cardiomyopathy	0.000917	0.0291	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000896	0.0284	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000843	0.0267	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.000815	0.0258	CbGpPWpGaD
Trilostane—ESR1—Nuclear signaling by ERBB4—PSEN2—dilated cardiomyopathy	0.000737	0.0234	CbGpPWpGaD
Trilostane—HSD3B1—Corticotropin-releasing hormone—RAF1—dilated cardiomyopathy	0.000714	0.0226	CbGpPWpGaD
Trilostane—ESR1—LKB1 signaling events—PSEN2—dilated cardiomyopathy	0.000682	0.0216	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000675	0.0214	CbGpPWpGaD
Trilostane—HSD3B2—Corticotropin-releasing hormone—RAF1—dilated cardiomyopathy	0.000541	0.0172	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000527	0.0167	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—TAZ—dilated cardiomyopathy	0.000495	0.0157	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—NPPA—dilated cardiomyopathy	0.000477	0.0151	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—SDHA—dilated cardiomyopathy	0.000448	0.0142	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—ANKRD1—dilated cardiomyopathy	0.000399	0.0127	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—TAZ—dilated cardiomyopathy	0.000375	0.0119	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.000345	0.0109	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.00034	0.0108	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—SDHA—dilated cardiomyopathy	0.000339	0.0108	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—NR3C2—dilated cardiomyopathy	0.000335	0.0106	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000318	0.0101	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—GJA1—dilated cardiomyopathy	0.000305	0.00966	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000276	0.00875	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000273	0.00866	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000266	0.00843	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—IL10—dilated cardiomyopathy	0.000264	0.00838	CbGpPWpGaD
Trilostane—ESR1—Regulation of Telomerase—RPS6KB1—dilated cardiomyopathy	0.000263	0.00834	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—PSEN2—dilated cardiomyopathy	0.000248	0.00787	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—RPS6KB1—dilated cardiomyopathy	0.000243	0.00771	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.00024	0.00759	CbGpPWpGaD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—dilated cardiomyopathy	0.000235	0.00745	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—AGT—dilated cardiomyopathy	0.000222	0.00703	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—RAC1—dilated cardiomyopathy	0.00022	0.00697	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.000218	0.00692	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.000215	0.00683	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	0.00021	0.00667	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.00021	0.00667	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000207	0.00656	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.000206	0.00654	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000202	0.00639	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000182	0.00575	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—NR3C2—dilated cardiomyopathy	0.000169	0.00536	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—NR3C2—dilated cardiomyopathy	0.000161	0.00511	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.000148	0.00468	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—RAF1—dilated cardiomyopathy	0.000146	0.00462	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	0.000141	0.00446	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.000137	0.00434	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—RAC1—dilated cardiomyopathy	0.000126	0.00398	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—GPX1—dilated cardiomyopathy	0.000122	0.00386	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—CD36—dilated cardiomyopathy	0.000118	0.00376	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.00011	0.00349	CbGpPWpGaD
Trilostane—ESR1—Regulation of Telomerase—EGFR—dilated cardiomyopathy	0.000108	0.00343	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—AGT—dilated cardiomyopathy	0.000107	0.00338	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	0.000106	0.00336	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.000106	0.00336	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000105	0.00333	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.000104	0.0033	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—NPPA—dilated cardiomyopathy	0.000101	0.00321	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	9.38e-05	0.00297	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—GPX1—dilated cardiomyopathy	9.22e-05	0.00292	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—CD36—dilated cardiomyopathy	8.98e-05	0.00285	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	8.93e-05	0.00283	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—RAF1—dilated cardiomyopathy	8.28e-05	0.00263	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—NR3C2—dilated cardiomyopathy	8.14e-05	0.00258	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—AGT—dilated cardiomyopathy	8.08e-05	0.00256	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	6.9e-05	0.00219	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—EGFR—dilated cardiomyopathy	5.71e-05	0.00181	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—EGFR—dilated cardiomyopathy	5.68e-05	0.0018	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—NPPA—dilated cardiomyopathy	5.11e-05	0.00162	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	4.73e-05	0.0015	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	4.51e-05	0.00143	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PSEN2—dilated cardiomyopathy	3.22e-05	0.00102	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.86e-05	0.000905	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.86e-05	0.000905	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.66e-05	0.000842	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.57e-05	0.000815	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.2e-05	0.000696	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.08e-05	0.000661	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.79e-05	0.000568	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—RAC1—dilated cardiomyopathy	1.62e-05	0.000513	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—AGT—dilated cardiomyopathy	1.55e-05	0.00049	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—RAF1—dilated cardiomyopathy	1.07e-05	0.00034	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—EGFR—dilated cardiomyopathy	7.36e-06	0.000233	CbGpPWpGaD
